Drugs / MK0787B
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00445094 | Nov 2006 → Jan 2007 | pneumonia | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MK0787B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00445094 ↗ |
| Known as | imipenem/cilastatin sodium | “MK0787B, imipenem/cilastatin sodium / Duration of Treatment: 7 Days” NCT00445094 ↗ |